Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Addiction Journal Club - From Treatment to Risk? Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?

May 27, 2025
12:00 pm–1:00 pm ET

A session open to individuals working in the field of addiction where we discuss an evidence-based article with implications for substance use disorder practice. This month, we will be joined by one of the authors, Tim Wilens, MD, to review and discuss “Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?" by McCabe, S. E., Figueroa, O., McCabe, V. V., Schepis, T. S., Schulenberg, J. E., Veliz, P. T., Werner, K. S., & Wilens, T. E.

NOTE: This is not an accredited continuing education activity.

Register now

Virtual meeting

Via Zoom

Description

Addiction Journal Club (AJC) is a monthly session where we meet to review an evidence-based article and discuss its implications for substance use disorder (SUD) practice. This includes new research and landmark studies relevant to SUD practice. AJC is distinct from other BMC Grayken Center for Addiction TTA events; it is designed to be less didactic and more of an interactive review of emerging data and trends related to caring for persons who use substances. It is also a great opportunity to network with addiction colleagues and share experiences about clinical practices.

This month, we will be joined by one of the authors, Tim Wilens, MD, to review and discuss “Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?" by McCabe, S. E., Figueroa, O., McCabe, V. V., Schepis, T. S., Schulenberg, J. E., Veliz, P. T., Werner, K. S., & Wilens, T. E. Click here to read the open access article.

Intended audience

Individuals working in the field of addiction medicine.

Speakers

Tim Wilens, MD

Dr. Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital. He is the MGH Trustees Chair in Addiction Medicine and a professor of psychiatry at Harvard Medical School. 

Dr. Wilens earned his MD at the University of Michigan Medical School in Ann Arbor and completed his residency in child, adolescent and adult psychiatry at Mass General.

Dr. Wilens’ research interests include the relationship among attention deficit/hyperactivity disorder (ADHD), bipolar disorder, and substance use disorders; embedded health care models, and the pharmacotherapy of ADHD across the lifespan. He has published more than 300 peer-reviewed articles, concerning these and related topicsHe has also coedited more than 80 book chapters, 4 books, and 300 abstracts and presentations for national and international scientific meetings.

Dr. Wilens is a distinguished fellow of the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry and is on the editorial boards or is a scientific reviewer for more than 35 journals.

Sponsored by

Boston Medical Center Grayken Center for Addiction, Bureau of Substance Addiction Services (BSAS/DPH), Opioid Response Network (ORN)

Funding for this initiative was made possible (in part) by grant no. 1H79TI085588-02 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

This journal club session is not an accredited continuing education activity and does not offer continuing education credits. Only certificates of completion with no credits attached will be offered to registered participants who attend the session and complete the post-evaluation.

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2025 Boston Medical Center. All rights reserved. Site by Root802.